Preventing tuberculosis among HIV-infected pregnant women in lesotho: The case for rolling out active case finding and isoniazid preventive therapy

Journal of Acquired Immune Deficiency Syndromes

Volumn 67, Issue 1, 2014, Pages

  Tiam, Appolinaire ^a   Machekano, Rhoderick ^b   Gounder, Celine R ^c   Maama Maime, Llang B M ^d   Ntene Sealiete, Keletso ^d   Sahu, Maitreyi ^e   Isavwa, Anthony ^a   Oyebanji, Oyebola ^a   Ahimbisibwe, Allan ^a   Mokone, Majoalane ^a   Barnes, Grace L ^a   Chaisson, Richard E ^a   Guay, Laura ^f,g   Kassaye, Seble ^g  

^a ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION   (United States)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c New York Department of Health   (United States)

^d Research Coordination Unit   (Lesotho)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f GEORGE WASHINGTON UNIVERSITY   (United States)

^g GEORGETOWN UNIVERSITY   (United States)

Author keywords

HIV; pregnancy; prevention; therapy

Indexed keywords

EFAVIRENZ; ISONIAZID; LAMIVUDINE; NEVIRAPINE; TENOFOVIR; ZIDOVUDINE; TUBERCULOSTATIC AGENT;

ADULT; ANTIVIRAL THERAPY; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LESOTHO; MAJOR CLINICAL STUDY; PREGNANT WOMAN; PRIORITY JOURNAL; TUBERCULOSIS; TUBERCULOSIS CONTROL; VERTICAL TRANSMISSION; MICROBIOLOGY; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; PROCEDURES; PROSPECTIVE STUDY; STATISTICAL MODEL; VIROLOGY; YOUNG ADULT;

ADULT; ANTITUBERCULAR AGENTS; FEMALE; HIV INFECTIONS; HUMANS; ISONIAZID; LESOTHO; LOGISTIC MODELS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; PROSPECTIVE STUDIES; TUBERCULOSIS; YOUNG ADULT;

EID: 84906066590     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000209     Document Type: Conference Paper

References (28)

1. World Health Organization. TB/HIV Facts 2012-2013. 2012.
2. World Health Organization. Tuberculosis Women and TB. 2009.
3. Mnyani CN, McIntyre JA. Tuberculosis in pregnancy. BJOG. 2011;118: 226-231.
4. Bassett IV, Wang B, Chetty S, et al. Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa. Clin Infect Dis. 2010;51:823-829.
5. Gounder CR, Wada NI, Kensler C, et al. Active tuberculosis case-finding among pregnant women presenting to antenatal clinics in Soweto, South Africa. J Acquir Immune Defic Syndr. 2011;57:e77-e84.
6. Khan M, Pillay T, Moodley JM, et al. Maternal mortality associated with tuberculosis-HIV-1 co-infection in Durban, South Africa. AIDS. 2001; 15:1857-1863.
7. Gupta A, Bhosale R, Kinikar A, et al. Maternal tuberculosis: a risk factor for mother-to-child transmission of human immunodeficiency virus. J Infect Dis. 2011;203:358-363.
8. World Health Organization. Guidelines for Intensified Case Finding and Isoniazid Preventive Therapy for People Living with HIV in Resource-constrained Settings. 2011.
9. Kali PB, Gray GE, Violari A, et al. Combining PMTCT with active case finding for tuberculosis. J Acquir Immune Defic Syndr. 2006;42:379-381.
10. Thorson A, Hoa NP, Long NH, et al. Do women with tuberculosis have a lower likelihood of getting diagnosed? Prevalence and case detection of sputum smear positive pulmonary TB, a population-based study from Vietnam. J Clinical Epidemiology. 2004;57:398-402.
11. Sheriff FG, Manji KP, Manji MP, et al. Latent tuberculosis among pregnant mothers in a resource poor setting in Northern Tanzania: a cross-sectional study. BMC Infect Dis. 2010;10:52.
12. Keskin N, Yilmaz S. Pregnancy and tuberculosis: to assess tuberculosis cases in pregnancy in a developing region retrospectively and two case reports. Arch Gynecol Obstet. 2008;278:451-455.
13. Getahun H, Sculier D, Sismanidis C, et al. Prevention, diagnosis, and treatment of tuberculosis in children and mothers: evidence for action for maternal, neonatal, and child health services. J Infect Dis. 2012;205 (suppl 2):S216-S227.
14. Durovni B, Cavalcante SC, Saraceni V, et al. The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) study. AIDS. 2010;24(suppl 5):S49-S56.
15. Munseri PJ, Talbot EA, Mtei L, et al. Completion of isoniazid preventive therapy among HIV-infected patients in Tanzania. Int J Tuberc Lung Dis. 2008;12:1037-1041.
16. Khawcharoenporn T, Apisarnthanarak A, Manosuthi W, et al. Isoniazid preventive therapy and 4-year incidence of pulmonary tuberculosis among HIV-infected Thai patients. Int J Tuberc Lung Dis. 2012;16: 336-341.
17. Golub JE, Pronyk P, Mohapi L, et al. Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort. AIDS. 2009;23:631-636.
18. Ministry of Health Lesotho. National Guidelines for 3Is, IPT/ICF/IC. 1st ed. 2011.
19. Bristow CC, Larson E, Vilakazi-Nhlapo AK, et al. Scale-up of isoniazid preventive therapy in PEPFAR-Assisted clinical sites in South Africa. Int J Tuberc Lung Dis. 2012;16:1020-1022.
20. Chehab JC, Vilakazi-Nhlapo K, Vranken P, et al. Survey of isoniazid preventive therapy in South Africa, 2011. Int J Tuberc Lung Dis. 2012; 16:903-907.
21. Getahun H, Granich R, Sculier D, et al. Implementation of isoniazid preventive therapy for people living with HIV worldwide: barriers and solutions. AIDS. 2010;24(suppl 5):S57-S65.
22. Horsburgh CR Jr, Goldberg S, Bethel J, et al. Latent TB infection treatment acceptance and completion in the United States and Canada. Chest. 2010;137:401-409.
23. Kwara A, Herold JS, Machan JT, et al. Factors associated with failure to complete isoniazid treatment for latent tuberculosis infection in Rhode Island. Chest. 2008;133:862-868.
24. Taylor AW, Mosimaneotsile B, Mathebula U, et al. Pregnancy outcomes in HIV-infected women receiving long-term isoniazid prophylaxis for tuberculosis and antiretroviral therapy. Infect Dis Obstet Gynecol. 2013;2013:195637.
25. Ouyang DW, Shapiro DE, Lu M, et al. Increased risk of hepatotoxicity in HIV-infected pregnant women receiving antiretroviral therapy independent of nevirapine exposure. AIDS. 2009;23:2425-2430.
26. Lyons F, Hopkins S, Kelleher B, et al. Maternal hepatotoxicity with nevirapine as part of combination antiretroviral therapy in pregnancy. HIV Med. 2006;7:255-260.
27. Rangaka MX, Wilkinson RJ, Boulle A, et al. Randomized controlled trial of isoniazid preventive therapy in HIV-infected persons on antiretroviral therapy. 19th International AIDS Conference; 2012.
28. McDougal L, Moteetee MM, Mohai F, et al. Lesotho's minimum PMTCT package: lessons learned for combating vertical HIV transmission using co-packaged medicines. J Int AIDS Soc. 2012;15:17326.